| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |